Giulio Superti-Furga (born 17 May 1962 in Milan) is an Italian molecular and systems biologist based in Vienna, Austria. He is the Scientific Director of CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), and Professor of Medical Systems Biology at the Medical University of Vienna. Among his most significant scientific achievements to date are the elucidation of basic regulatory mechanisms of tyrosine kinases in human cancers, the identification of the molecular mechanisms of several drugs, and the discovery of fundamental organization principles of the proteome and the lipidome of higher organisms, as well as the characterization of molecular components relevant for innate immunity. His work has directly contributed to a systems-level understanding of pathogen infections in host cells and of the mechanism of action of specific drugs. He is an advocate for the adoption of systems biology approaches for medicine and in particular for drug discovery. Recently, he focused his research on membrane transporters, which are at the interface between biological systems and the environment. Despite their relevance for medicine and drug discovery, these proteins remain understudied and demand a intensive systematic study. In 2008, he was awarded the Knight Officer Order of Merit of the Republic of Italy for his contributions to science. In 2011, Giulio Superti-Furga was awarded with the prize of the City of Vienna for natural sciences and designated as "Austria’s Scientist of the Year". In June 2017, was awarded the title of Commendatore (Commander) dell'Ordine al Merito della Repubblica Italiana (Order of Merit of the Italian Republic) by HE Giorgio Marrapodi, Ambassador of Italy.He is the brother of Andrea Superti-Furga, pediatrician and geneticist based in Switzerland. Source: Wikipedia (en)